Albini A, Magnani E, Noonan DM (2010) The tumor microenvironment: biology of a complex cellular and tissue society. The quarterly journal of nuclear medicine and molecular imaging: official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of 54:244-248
Barber TD, Derinkuyu BE, Wickiser J, Joglar J, Koral K, Baker LA (2011) Wilms tumor: preoperative risk factors identified for intraoperative tumor spill. The Journal of Urology 185:1414-1418
Carla V, Nella P, Federica L, Gianni M (2015) Tumor-associated mast cells in thyroid cancer. International Journal of Endocrinology 2015:1-8
Caro GD Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A (2014) Occurrence of tertiary lymphoid tissue is associated with t-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clinical Cancer Research 20:2147-2158
Corgna E, Betti M, Gatta G, Roila F, Mulder PHMD (2007) Renal cancer. Critical Reviews in Oncology/Hematology 64:247-262
Davidoff AM (2012) Wilms' tumor. Advances in Pediatrics 59:247-267
Donskov F (2006) Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. Journal of Clinical Oncology 24:1997-2005
Erdag G, Schaefer JT, Smolkin ME, Deacon DH, Shea SM, Dengel LT (2012) Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Research 72:1070-1080
Ehrlich PF (2017) Wilms Tumor. Fundamentals of Pediatric Surgery. Springer International Publishing.
Gannon PO, Poisson AO, Delvoye N, Réjean Lapointe, Mes-Masson AM, Saad F (2009) Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients. Journal of Immunological Methods 348: 9-17
Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, Kanai Y (2013) Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. British Journal of Cancer 108:914-923
Isaac A, Sharma B (2015) Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. Journal of Functional Biomaterials 6:81-103
Jiang B, Mason J, Jewett A, Liu ML, Man YG (2013) Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?. International journal of medical sciences 10:475-497
Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, Von DMH (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. Journal of Clinical Oncology 27:4709-4717
Jochems C, Schlom J (2011) Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Experimental Biology and Medicine 236:567-579
Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H (2011) Il-17 is associated with poor prognosis and promotes angiogenesis via stimulating vegf production of cancer cells in colorectal carcinoma. Biochemical & Biophysical Research Communications 407:348-354
Liu X, Wu S, Yang Y, Zhao M, Zhu G, Hou Z (2017) The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer. Biomedicine & Pharmacotherapy 95:55-61
Njuguna F, Martijn HA, Kuremu RT, Saula P, Kirtika P, Olbara G (2017) Wilms tumor treatment outcomes: perspectives from a low-income setting. Journal of Global Oncology 3:555-562
Perotti D, Hohenstein P, Bongarzone I, Maschietto M, Weeks M, Radice P (2013) Is wilms tumor a candidate neoplasia for treatment with wnt/β-catenin pathway modulators?—a report from the renal tumors biology-driven drug development workshop. Molecular Cancer Therapeutics 12:2619-2627
Rooney M, Shukla S, Wu C, Getz G, Hacohen N (2015) Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160:48-61
Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E (1999) Interleukin 17, a t-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Research 59:3698
Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC (2007) Pd-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clinical Cancer Research 13: 1757-1761
Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R (2011) Interaction of tumor cells with the microenvironment. Cell Communication and Signaling 9:18
Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL (2006) Mononuclear cell infiltration in clear‐cell renal cell carcinoma independently predicts patient survival. Cancer 107
Weir HK, Johnson CJ, Ward KC, Coleman MP (2016) The effect of multiple primary rules on cancer incidence rates and trends. Cancer Causes & Control 27:377-390.
Xiong Y, Wang K, Zhou H, Peng L, You W, Fu Z (2018) Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study. Cancer Med 7:4496-4508